201
|
Towards the production of monodisperse gelatin nanoparticles by modified one step desolvation technique. JOURNAL OF PHARMACEUTICAL INVESTIGATION 2019. [DOI: 10.1007/s40005-019-00455-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
202
|
Rezaei R, Safaei M, Mozaffari HR, Moradpoor H, Karami S, Golshah A, Salimi B, Karami H. The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System. Open Access Maced J Med Sci 2019; 7:1884-1890. [PMID: 31316678 PMCID: PMC6614262 DOI: 10.3889/oamjms.2019.486] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2019] [Revised: 05/27/2019] [Accepted: 05/28/2019] [Indexed: 12/12/2022] Open
Abstract
Nanotechnology has been widely exploited in recent years in various applications. Different sectors of medicine and treatment have also focused on the use of nanoproducts. One of the areas of interest in the treatment measures is the interaction between nanomaterials and immune system components. Engineered nanomaterials can stimulate the inhibition or enhancement of immune responses and prevent the detection ability of the immune system. Changes in immune function, in addition to the benefits, may also lead to some damage. Therefore, adequate assessment of the novel nanomaterials seems to be necessary before practical use in treatment. However, there is little information on the toxicological and biological effects of nanomaterials, especially on the potential ways of contacting and handling nanomaterials in the body and the body response to these materials. Extensive variation and different properties of nanomaterials have made it much more difficult to access their toxicological effects to the present. The present study aims to raise knowledge about the potential benefits and risks of using the nanomaterials on the immune system to design and safely employ these compounds in therapeutic purposes.
Collapse
Affiliation(s)
- Razieh Rezaei
- Advanced Dental Sciences Research Laboratory, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.,Medical Biology Research Centre, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Mohsen Safaei
- Advanced Dental Sciences Research Laboratory, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Hamid Reza Mozaffari
- Medical Biology Research Centre, Kermanshah University of Medical Sciences, Kermanshah, Iran.,Department of Oral and Maxillofacial Medicine, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Hedaiat Moradpoor
- Department of Prosthodontics, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Sara Karami
- Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Amin Golshah
- Department of Orthodontics, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Behroz Salimi
- School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Hossein Karami
- School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
| |
Collapse
|
203
|
Kaundal B, Srivastava AK, Sardoiwala MN, Karmakar S, Choudhury SR. A NIR-responsive indocyanine green-genistein nanoformulation to control the polycomb epigenetic machinery for the efficient combinatorial photo/chemotherapy of glioblastoma. NANOSCALE ADVANCES 2019; 1:2188-2207. [PMID: 36131972 PMCID: PMC9419092 DOI: 10.1039/c9na00212j] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Accepted: 04/13/2019] [Indexed: 06/15/2023]
Abstract
Combinatorial photodynamics and chemotherapy have drawn enormous attention as therapeutic modalities via precise stimuli-responsive drug delivery for glioblastoma, which can overcome the limitations associated with conventional therapies. Herein, we have prepared an indocyanine green tagged, genistein encapsulated casein nanoformulation (ICG-Gen@CasNPs) that exhibits the near infra-red region responsive controlled release of genistein and enhanced cellular uptake in the human glioblastoma monolayer and a three-dimensional raft culture model via the enhanced retention effect. ICG-Gen@CasNPs, with the integrated photosensitizer indocyanine green within the nanoformulation, triggered oxidative stress, activating the apoptosis cascade, promoting cell cycle arrest and damaging the mitochondrial membrane potential, collectively directing glioblastoma cell death. The suppression of the polycomb group of proteins in the glioblastoma upon ICG-Gen@CasNPs/NIR exposure revealed the involvement of the epigenetic repression complex machinery in the regulation. Furthermore, ICG-Gen@CasNPs/PDT/PTT directed ubiquitination and proteasomal degradation of EZH2 and BMI1 indicates the implication of the polycomb in conferring glioblastoma survival. The increased activation of the apoptotic pathways and the generation of cellular reactive oxygen species upon inhibiting the expression of EZH2 and BMI1 strengthen our observations. It is worth noting that ICG-Gen@CasNPs robustly accumulated in the brain after crossing the blood-brain barrier, which represents the eminent biocompatibility and means that the system is devoid of any nonspecific toxicity in vivo. Moreover, a superior anti-tumor effect was demonstrated on a three-dimensional glioma spheroid model. Thus, this combinatorial chemo/photodynamic therapy revealed that ICG-Gen@CasNPs mediated epigenetic regulation, which is a crucial molecular mechanism of GBM suppression.
Collapse
Affiliation(s)
- Babita Kaundal
- Institute of Nano Science and Technology, Habitat Centre Phase-10, Sector 64 Mohali Punjab India
| | - Anup K Srivastava
- Institute of Nano Science and Technology, Habitat Centre Phase-10, Sector 64 Mohali Punjab India
| | | | - Surajit Karmakar
- Institute of Nano Science and Technology, Habitat Centre Phase-10, Sector 64 Mohali Punjab India
| | - Subhasree Roy Choudhury
- Institute of Nano Science and Technology, Habitat Centre Phase-10, Sector 64 Mohali Punjab India
| |
Collapse
|
204
|
Farooq MA, Aquib M, Ghayas S, Bushra R, Haleem Khan D, Parveen A, Wang B. Whey protein: A functional and promising material for drug delivery systems recent developments and future prospects. POLYM ADVAN TECHNOL 2019. [DOI: 10.1002/pat.4676] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Muhammad Asim Farooq
- Department of Pharmaceutics, School of PharmacyChina Pharmaceutical University Nanjing Jiangsu 211198 PR China
| | - Md Aquib
- Department of Pharmaceutics, School of PharmacyChina Pharmaceutical University Nanjing Jiangsu 211198 PR China
| | - Sana Ghayas
- Dow College of PharmacyDow University of Health Sciences Karachi Pakistan
| | - Rabia Bushra
- Dow College of PharmacyDow University of Health Sciences Karachi Pakistan
| | - Daulat Haleem Khan
- Department of PharmacyLahore College of Pharmaceutical Sciences Lahore Pakistan
| | - Amna Parveen
- College of PharmacyGachon University Incheon 21936 Korea
| | - Bo Wang
- Department of Pharmaceutics, School of PharmacyChina Pharmaceutical University Nanjing Jiangsu 211198 PR China
| |
Collapse
|
205
|
Wang L, Subasic C, Minchin RF, Kaminskas LM. Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastases. Nanomedicine (Lond) 2019; 14:1605-1621. [PMID: 31166140 DOI: 10.2217/nnm-2018-0478] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Lymphatic metastasis plays an important role in cancer progression and prognosis. However, conventional small-molecule chemotherapy drugs inefficiently access the lymphatic system, making the effective eradication of lymphatic metastases difficult without dose-limiting toxicity. Various formulation and nanomedicine-based approaches can be used to significantly enhance the trafficking of small-molecule, peptide and protein drugs toward the lymphatic system to enhance drug exposure at sites of lymphatic cancer growth. However, a number of obstacles exist in translating improved lymphatic exposure into improved chemotherapeutic outcomes. This review highlights the opportunities and challenges inherent in employing formulation and nanomedicinal approaches to improve chemotherapeutic drug activity within the lymphatic system and, importantly, at sites of lymphatic cancer metastasis.
Collapse
Affiliation(s)
- Lili Wang
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia
| | - Christopher Subasic
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia
| | - Rodney F Minchin
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia
| | - Lisa M Kaminskas
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia
| |
Collapse
|
206
|
VandenBerg MA, Webber MJ. Biologically Inspired and Chemically Derived Methods for Glucose-Responsive Insulin Therapy. Adv Healthc Mater 2019; 8:e1801466. [PMID: 30605265 DOI: 10.1002/adhm.201801466] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 12/11/2018] [Indexed: 12/13/2022]
Abstract
The controlled delivery of therapeutics in a manner responsive to physiological indicators has promise in realizing new therapeutic approaches to combat disease. This approach is especially relevant in the context of diabetes. Natural fluctuations in blood glucose seen in the healthy state, complete with peaks and troughs, are poorly regulated as a result of detrimental production or ineffective signaling of the insulin hormone. While several manifestations of diabetes are treated with regularly administered exogenous insulin, the present standard of care results in suboptimal glycemic management that poorly recreates natural hormone control, leading to long-term instability and a significantly increased risk for secondary health complications. New synthetic technologies that make insulin available only when needed, and at the exact dose required, have been explored under the broad vision of realizing a "fully synthetic pancreas." Yet, many challenges remain to realizing a technology that is appropriately responsive, safe, and well integrated into a manageable routine. Herein, many of the approaches explored thus far to sense physiological blood glucose and elicit response through the release of therapeutic insulin are summarized. The approaches point to a new, autonomous approach to managing diabetes with biomimetic therapy.
Collapse
Affiliation(s)
- Michael A. VandenBerg
- Department of Chemical & Biomolecular EngineeringUniversity of Notre Dame 205 McCourtney Hall Notre Dame IN 46556 USA
| | - Matthew J. Webber
- Department of Chemical & Biomolecular EngineeringUniversity of Notre Dame 205 McCourtney Hall Notre Dame IN 46556 USA
| |
Collapse
|
207
|
Ma B, Niu F, Qu X, He W, Feng C, Wang S, Ouyang Z, Yan J, Wen Y, Xu D, Shao Y, Ma PX, Lu W. A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy. Biomaterials 2019; 204:1-12. [PMID: 30861422 PMCID: PMC6441627 DOI: 10.1016/j.biomaterials.2019.03.004] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 03/04/2019] [Accepted: 03/05/2019] [Indexed: 12/15/2022]
Abstract
A major pharmacological barrier to peptide therapeutics is their susceptibility to proteolytic degradation and poor membrane permeability, which, in principle, can be overcome by nanoparticle-based delivery technologies. Proteins, by definition, are nano materials and have been clinically proven as an efficient delivery vehicle for small molecule drugs. Here we describe the design of a protein-based peptide drug carrier derived from the tetramerization domain of the chimeric oncogenic protein Bcr/Abl of chronic myeloid leukemia. A dodecameric peptide inhibitor of the p53-MDM2/MDMX interaction, termed PMI, was grafted to the N-terminal helical region of Bcr/Abl tetramer. To antagonize intracellular MDM2/MDMX for p53 activation, we extended this protein, PMIBcr/Abl, by a C-terminal Arg-repeating hexapeptide to facilitate its cellular uptake. The resultant tetrameric protein PMIBcr/Abl-R6 adopted an alpha-helical conformation in solution and bound to MDM2 at an affinity of 32 nM. PMIBcr/Abl-R6 effectively induced apoptosis of HCT116 p53+/+ cells in vitro in a p53-dependent manner and potently inhibited tumor growth in a nude mouse xenograft model by stabilizing p53 in vivo. Our protein-based delivery strategy thus provides a clinically viable solution to p53-inspired anticancer therapy and is likely applicable to the development of many other peptide therapeutics to target a great variety of intracellular protein-protein interactions responsible for disease initiation and progression.
Collapse
Affiliation(s)
- Bohan Ma
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
| | - Fan Niu
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
| | - Xiaoyan Qu
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Wangxiao He
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
| | - Chao Feng
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Simeng Wang
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Zhenlin Ouyang
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Jin Yan
- Center for Bioengineering and Regenerative Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China; Department of Biologic and Materials Sciences, Department of Biomedical Engineering, Macromolecular Science and Engineering Center, Department of Materials Science and Engineering, University of Michigan, Ann Arbor, MI, 48109, USA
| | - Yurong Wen
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Dan Xu
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China; Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
| | - Yongping Shao
- Center for Translational Medicine, Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Peter X Ma
- Department of Biologic and Materials Sciences, Department of Biomedical Engineering, Macromolecular Science and Engineering Center, Department of Materials Science and Engineering, University of Michigan, Ann Arbor, MI, 48109, USA
| | - Wuyuan Lu
- Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
| |
Collapse
|
208
|
Yalcin E, Kara G, Celik E, Pinarli FA, Saylam G, Sucularli C, Ozturk S, Yilmaz E, Bayir O, Korkmaz MH, Denkbas EB. Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment. Prep Biochem Biotechnol 2019; 49:659-670. [DOI: 10.1080/10826068.2019.1599395] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Eda Yalcin
- Nanoscience and Nanomedicine Division, Hacettepe University, Ankara, Turkey
| | - Goknur Kara
- Department of Chemistry, Biochemistry Division, Hacettepe University, Ankara, Turkey
| | - Ekin Celik
- Bioengineering Division, Hacettepe University, Ankara, Turkey
| | - Ferda Alpaslan Pinarli
- Department of Stem Cell and Genetic Diagnostic Center, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Guleser Saylam
- Department of Otolaryngology, Head and Neck Surgery, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Ceren Sucularli
- Department of Bioinformatics, Institute of Health Sciences, Hacettepe University, Ankara, Turkey
| | - Serhat Ozturk
- Department of Chemistry, Biochemistry Division, Hacettepe University, Ankara, Turkey
| | - Esin Yilmaz
- Advanced Technologies Application& Research Center, Hacettepe University, Ankara, Turkey
| | - Omer Bayir
- Department of Otolaryngology, Head and Neck Surgery, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Mehmet Hakan Korkmaz
- Department of Otolaryngology, Head and Neck Surgery, Yildirim Beyazit University Medical School, Ankara, Turkey
| | - Emir Baki Denkbas
- Department of Chemistry, Biochemistry Division, Hacettepe University, Ankara, Turkey
- Faculty of Engineering, Department of Biomedical Engineering, Başkent University, Ankara, Turkey
| |
Collapse
|
209
|
Kloypan C, Suwannasom N, Chaiwaree S, Prapan A, Smuda K, Baisaeng N, Pruß A, Georgieva R, Bäumler H. In-vitro haemocompatibility of dextran-protein submicron particles. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2019; 47:241-249. [PMID: 30663396 DOI: 10.1080/21691401.2018.1548476] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Blood compatibility is a key requirement to fulfil for intravenous administration of drug and oxygen carrier system. Recently, we published the fabrication of oxidised-dextran (Odex)-crosslinked protein particles by one-pot formulation. In the current study we investigate the haemocompatibility of these Odex - particles including albumin particles (Odex-APs) and haemoglobin particles (Odex-HbMPs). Odex-APs and Odex-HbMPs have a submicron size ranged 800-1000 nm with peanut-like shape and a negative surface charge. In vitro haemocompatibility assays included haemolysis test, indirect phagocytosis test and platelet activation test in human blood. Odex-APs and Odex-HbMPs did not provoke any undesirable effects on the blood cells. Firstly, the ratio of haemolysis after contacted with Odex-crosslinked protein particles were less than 5% and therefore the particles may be considered non-haemolytic. Secondly, the incubation of leukocyte with Odex-APs/HbMPs did not influence the phagocytosis of leukocyte. We conclude that our particles are not recognized by monocytes or granulocytes. Finally, exposure of Odex-APs/HbMPs to platelets did not cause an activation of platelets. Additionally, Odex-HbMP/AP did not enhance or attenuate agonist-induced platelet activation. We conclude that Odex-crosslinked protein particles exhibit a very good haemocompatibility and represent highly promising carriers for drugs or oxygen.
Collapse
Affiliation(s)
- Chiraphat Kloypan
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany.,b Division of Clinical Immunology and Transfusion Sciences, School of Allied Health Sciences , University of Phayao , Phayao , Thailand
| | - Nittiya Suwannasom
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany.,c Division of Biochemistry and Nutrition, School of Medical Sciences , University of Phayao , Phayao , Thailand
| | - Saranya Chaiwaree
- d Department of Radiological Technology, Faculty of Allied Health Sciences , Naresuan University , Phitsanulok , Thailand
| | - Ausanai Prapan
- e Department of Pharmaceutical Technology, Faculty of Pharmacy , Payap University , Chiang Mai , Thailand
| | - Kathrin Smuda
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany
| | - Nuttakorn Baisaeng
- f Division of Pharmaceutical Sciences, School of Pharmaceutical Sciences , University of Phayao , Phayao , Thailand
| | - Axel Pruß
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany
| | - Radostina Georgieva
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany.,g Department of Medical Physics, Biophysics and Radiology, Faculty of Medicine , Trakia University , Stara Zagora , Bulgaria
| | - Hans Bäumler
- a Institute of Transfusion Medicine , Charité-Universitätsmedizin Berlin , Berlin , Germany
| |
Collapse
|
210
|
Du Y, Chen B. Combination of drugs and carriers in drug delivery technology and its development. DRUG DESIGN DEVELOPMENT AND THERAPY 2019; 13:1401-1408. [PMID: 31118575 PMCID: PMC6500434 DOI: 10.2147/dddt.s198056] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/13/2018] [Accepted: 04/01/2019] [Indexed: 01/02/2023]
Abstract
The development of drug-loading technology will bring new and rapid development to the treatment of diseases. At present, drug delivery by nanoparticles, erythrocyte, and platelet have been studied extensively. Compared with traditional anticancer drugs, nano-drugs have shown many obvious advantages, disease treatment based on nanotechnology will bring a revolution in cancer treatment. Due to its inherent biocompatibility, large drug load and long half-life in the blood circulation, erythrocyte-inspired antibiotics, and some anticancer drugs delivery systems have also entered the clinical trial stage. At present, there are relatively few studies on drug delivery by platelets as carriers. It is necessary to overcome the shortcomings of platelets, such as easy activation, deformation, thrombosis, and difficult preservation. There are many ways to combine drugs with these carriers, and each has its own advantages and disadvantages. It is necessary to seek the best combination scheme to increase drug loading and reduce the damage to therapeutic components to the carriers, so as to bring more mature and reliable methods for the clinical application of drug delivery technology. Several drug-loading technologies and their development were described according to various categories. The combination of drugs and carriers is summarized for better understanding of its practical application.
Collapse
Affiliation(s)
- Ying Du
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Baoan Chen
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| |
Collapse
|
211
|
Mukherjee A, Paul M, Mukherjee S. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer. Cancers (Basel) 2019; 11:cancers11050597. [PMID: 31035440 PMCID: PMC6562381 DOI: 10.3390/cancers11050597] [Citation(s) in RCA: 51] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2019] [Revised: 04/27/2019] [Accepted: 04/27/2019] [Indexed: 12/24/2022] Open
Abstract
Lung cancer is one of the leading causes of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) causes around 80% to 90% of deaths. The lack of an early diagnosis and inefficiency in conventional therapies causes poor prognosis and overall survival of lung cancer patients. Recent progress in nanomedicine has encouraged the development of an alternative theranostics strategy using nanotechnology. The interesting physico-chemical properties in the nanoscale have generated immense advantages for nanoparticulate systems for the early detection and active delivery of drugs for a better theranostics strategy for lung cancer. This present review provides a detailed overview of the recent progress in the theranostics application of nanoparticles including liposomes, polymeric, metal and bio-nanoparticles. Further, we summarize the advantages and disadvantages of each approach considering the improvement for the lung cancer theranostics.
Collapse
Affiliation(s)
- Anubhab Mukherjee
- Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Providence Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA.
| | - Manash Paul
- Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, The University of California, Los Angeles (UCLA) Factor Bldg. 10-240, 621 Charles E. Young Dr., Los Angeles, CA 90095, USA.
| | - Sudip Mukherjee
- Department of Bioengineering, Rice University, 6500 Main Street, Houston, TX 77005, USA.
| |
Collapse
|
212
|
Park S, Kim H, Lim SC, Lim K, Lee ES, Oh KT, Choi HG, Youn YS. Gold nanocluster-loaded hybrid albumin nanoparticles with fluorescence-based optical visualization and photothermal conversion for tumor detection/ablation. J Control Release 2019; 304:7-18. [PMID: 31028785 DOI: 10.1016/j.jconrel.2019.04.036] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Revised: 04/02/2019] [Accepted: 04/23/2019] [Indexed: 12/29/2022]
Abstract
Gold nanoclusters (AuNCs) are viewed as effective hyperthermal agents for the treatment of tumors. Whereas AuNCs formed by the agglomeration of several to tens of gold atoms (<1-2 nm) possess significant fluorescence, they have a negligible hyperthermal effect, while AuNCs comprised of spherical gold nanoparticles (AuNPs > a few nanometers) have a marked hyperthermic effect but lose their inherent fluorescence and obstruct the intensity of neighboring fluorescent dyes due to Forster resonance energy transfer (FRET). To achieve both hyperthermia and fluorescence-based optical visualization, we generated hybrid albumin nanoparticles containing AuNCs (~88 nm) comprising AuNPs (~4.5 nm). We generated a series of formulated AuNCs and optimized the size, morphology, NIR absorbance (600-900 nm), hyperthermal activity, and fluorescence spectral characters of the resulting hybrid albumin nanoparticles (AuNCs/BSA-NPs) by considering the interparticle distance between the AuNPs and Cy5.5. Among these, AuNCs/BSA-NPs (formula D) had a strong hyperthermic effect and had well-preserved fluorescence intensity (from the attached Cy5.5) due to localized surface plasmon resonance (LSPR) and a reduction in FRET. These AuNCs/BSA-NPs were able to elevate the surface tumor temperature of HCT116-bearing mice to >50 °C following 808 nm laser irradiation (1.5 W/cm2, 10 min), which remarkably suppressed tumor growth (17.8 ± 16.9 mm3vs. PBS and AuNCs/BSA-NPs (formula E): ~1850 and ~1250 mm3, respectively). Also, Cy5.5-modified AuNCs/BSA-NPs (formula D) showed good performance in optical fluorescence imaging of target tumors in HCT116 tumor-bearing mice. Together, our results indicate that the interparticle distance between albumin or Cy5.5 and AuNPs/AuNCs can be optimized to achieve both hyperthermia and fluorescence emission by striking a balance between LSPR and FRET effects. We believe that the AuNC/BSA-NPs formulation presented here can serve as a potential platform for both optically visualizing and treating colon cancers.
Collapse
Affiliation(s)
- Sanghyun Park
- School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Gyeonggi-do, Suwon 16419, Republic of Korea
| | - Hanju Kim
- School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Gyeonggi-do, Suwon 16419, Republic of Korea
| | - Su Chan Lim
- School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Gyeonggi-do, Suwon 16419, Republic of Korea
| | - Kyungseop Lim
- School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Gyeonggi-do, Suwon 16419, Republic of Korea
| | - Eun Seong Lee
- Division of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Gyeonggi-do, Bucheon-si 14662, Republic of Korea
| | - Kyung Taek Oh
- College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea
| | - Han-Gon Choi
- College of Pharmacy, Hanyang University, 55 Hanyangdaehak-ro, Sangnok-gu, Ansan 15588, Republic of Korea
| | - Yu Seok Youn
- School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Gyeonggi-do, Suwon 16419, Republic of Korea.
| |
Collapse
|
213
|
Liu X, Zhang B, Sohal IS, Bello D, Chen H. Is "nano safe to eat or not"? A review of the state-of-the art in soft engineered nanoparticle (sENP) formulation and delivery in foods. ADVANCES IN FOOD AND NUTRITION RESEARCH 2019; 88:299-335. [PMID: 31151727 DOI: 10.1016/bs.afnr.2019.03.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
With superior physicochemical properties, soft engineered nanoparticles (sENP) (protein, carbohydrate, lipids and other biomaterials) are widely used in foods. The preparation, functionalities, applications, transformations in gastrointestinal (GI) tract, and effects on gut microbiota of sENP directly incorporated for ingestion are reviewed herein. At the time of this review, there is no notable report of safety concerns of these nanomaterials found in the literature. Meanwhile, various beneficial effects have been demonstrated for the application of sENP. To address public perception and safety concerns of nanoscale materials in food, methodologies for evaluation of physiological effects of nanomaterials are reviewed. The combination of these complementary methods will be useful for the establishment of a comprehensive risk assessment system.
Collapse
Affiliation(s)
- Xiaobo Liu
- Department of Biomedical and Nutritional Sciences, University of Massachusetts, Lowell, MA, United States
| | - Boce Zhang
- Department of Biomedical and Nutritional Sciences, University of Massachusetts, Lowell, MA, United States.
| | - Ikjot Singh Sohal
- Purdue University, Center for Cancer Research, West Lafayette, IN, United States
| | - Dhimiter Bello
- Department of Biomedical and Nutritional Sciences, University of Massachusetts, Lowell, MA, United States.
| | - Hongda Chen
- U.S. Department of Agriculture, National Institute of Food and Agriculture, Washington DC, United States.
| |
Collapse
|
214
|
Deprey K, Becker L, Kritzer J, Plückthun A. Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization. Bioconjug Chem 2019; 30:1006-1027. [PMID: 30882208 PMCID: PMC6527423 DOI: 10.1021/acs.bioconjchem.9b00112] [Citation(s) in RCA: 52] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Biomolecules have many properties that make them promising for intracellular therapeutic applications, but delivery remains a key challenge because large biomolecules cannot easily enter the cytosol. Furthermore, quantification of total intracellular versus cytosolic concentrations remains demanding, and the determination of delivery efficiency is thus not straightforward. In this review, we discuss strategies for delivering biomolecules into the cytosol and briefly summarize the mechanisms of uptake for these systems. We then describe commonly used methods to measure total cellular uptake and, more selectively, cytosolic localization, and discuss the major advantages and drawbacks of each method. We critically evaluate methods of measuring "cell penetration" that do not adequately distinguish total cellular uptake and cytosolic localization, which often lead to inaccurate interpretations of a molecule's cytosolic localization. Finally, we summarize the properties and components of each method, including the main caveats of each, to allow for informed decisions about method selection for specific applications. When applied correctly and interpreted carefully, methods for quantifying cytosolic localization offer valuable insight into the bioactivity of biomolecules and potentially the prospects for their eventual development into therapeutics.
Collapse
Affiliation(s)
- Kirsten Deprey
- Department of Chemistry, Tufts University, 62 Talbot Avenue, Medford, Massachusetts 02155, United States
| | - Lukas Becker
- Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| | - Joshua Kritzer
- Department of Chemistry, Tufts University, 62 Talbot Avenue, Medford, Massachusetts 02155, United States
| | - Andreas Plückthun
- Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| |
Collapse
|
215
|
Majeed S, Aripin FHB, Shoeb NSB, Danish M, Ibrahim MNM, Hashim R. Bioengineered silver nanoparticles capped with bovine serum albumin and its anticancer and apoptotic activity against breast, bone and intestinal colon cancer cell lines. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2019; 102:254-263. [PMID: 31146998 DOI: 10.1016/j.msec.2019.04.041] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 03/24/2019] [Accepted: 04/12/2019] [Indexed: 01/21/2023]
Abstract
The aim of the current study was to biosynthesize the silver nanoparticles (AgNPs) from the bacterial strain of Bacillus cereus (ATCC 14579) extracellularly. When bacterial extract was challenged with 1 mM silver nitrate (AgNO3) the color of the extract changed into brown confirms the formation of nanoparticles. These nanoparticles were capped with bovine serum albumin (BSA). UV- visible spectroscopy showed the absorption peak at 420 nm indicates the formation of AgNPs. Fourier Infra -red (FTIR) attenuated total reflection (ATR) spectroscopy showed amide and amine group associated with AgNPs that stabilizes the nanoparticles. Energy dispersive x-ray spectroscopy (EDX) showed a strong peak of silver confirms the presence of silver. Thermo gravimetric analysis (TGA) analysis was used to determine the protein degradation showed less protein degradation at higher temperature confirms the stability of nanoparticles. Transmission electron microscopy (TEM) showed the AgNPs are well dispersed and spherical, and 5.37 nm to 17.19 whereas albumin coated nanoparticles are size ranges from 11.26 nm to 23.85 nm. The anticancer effect of capped AgNPs (cAgNPs) showed the IC50 value against breast cancer MCF-7 at 80 μg/mL, intestinal colon cancer HCT- 116 60 μg/mL, and bone cancer osteosarcoma MG-63 cell line80 μg/mL while against normal fibroblast cells 3T3 cells showed the IC50 value at 140 μg/mL. Lactate dehydrogenase assay (LDH) showed higher toxicity on MCF-7, HCT-116, and MG-63 cells. The apoptotic study clearly showed the blebbing of membrane, chromatin condensation due to the production of reactive oxygen species (ROS) by ethidium bromide and acridine orange dual staining method. The DNA analysis showed the complete fragmentation of the DNA of treated cells when compared with control cells.
Collapse
Affiliation(s)
- Shahnaz Majeed
- Faculty of Pharmacy and Health, Universiti Kuala Lumpur, Royal College of Medicine, Ipoh Perak, Malaysia, 30450.
| | - Farah Hanani Binti Aripin
- Faculty of Pharmacy and Health, Universiti Kuala Lumpur, Royal College of Medicine, Ipoh Perak, Malaysia, 30450
| | - Nur Syafiqah Binti Shoeb
- Faculty of Pharmacy and Health, Universiti Kuala Lumpur, Royal College of Medicine, Ipoh Perak, Malaysia, 30450
| | - Mohammed Danish
- Green Chemistry and Sustainable Engineering Technology Research Cluster, Universiti Kuala Lumpur Malaysian Institute of Chemical and Bioengineering Technology (MICET), Lot 1988, Kawasan Perindustrian Bandar Vendor, Taboh Naning, 78000 Alor Gajah, Melaka, Malaysia.
| | - M N Mohamad Ibrahim
- School of Chemical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia
| | - Rokiah Hashim
- Division of Bioresource, Paper and Coatings Technology, School of Industrial Technology, Universiti Sains Malaysia, 11800 Penang, Malaysia
| |
Collapse
|
216
|
Amore E, Manca ML, Ferraro M, Valenti D, La Parola V, Di Vincenzo S, Gjomarkaj M, Giammona G, Bondì ML, Pace E. Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment. Int J Pharm 2019; 562:351-358. [PMID: 30935915 DOI: 10.1016/j.ijpharm.2019.03.059] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2018] [Revised: 03/25/2019] [Accepted: 03/27/2019] [Indexed: 01/12/2023]
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the main health problems worldwide. It is characterised by chronic inflammation in the lungs that leads to progressive, chronic, largely irreversible airflow obstruction. The use of long-acting β agonists remain today the frontline treatment for COPD with the aim of minimizing side effects and enhancing therapeutic usefulness. To this purpose, in this paper, mucoadhesive solid lipid microparticles (SLMs) containing a long-acting β-2 agonist, Salmeterol Xinafoate (SX) were prepared, characterised (size, z-potential, aerodynamic diameter, turbidimetric evaluations, drug loading and entrapping efficiency) and tested in a model of bronchial epithelial cells. It was demonstrated that the incorporation of SX into SLMs led to the production of particles suitable for inhalation and more efficient than the free molecule at increasing the cAMP expression in bronchial epithelial cells. In conclusion, the prepared systems, due to their aerodynamic behaviour and mucoadhesive properties, could improve the retention time of SX in the lung epithelium and its therapeutic effect, thus representing a good strategy for the treatment of COPD patients.
Collapse
Affiliation(s)
- Erika Amore
- Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy; Istituto per lo Studio dei Materiali Nanostrutturati (ISMN), U.O.S. Palermo, CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy
| | - Maria Letizia Manca
- Dipartimento Scienze della Vita e dell'Ambiente, Sezione Scienze del Farmaco, Università degli Studi di Cagliari, Via Ospedale 72, 09124 Cagliari, Italy
| | - Maria Ferraro
- Istituto di Biomedicina e Immunologia Molecolare (IBIM), CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy
| | - Donatella Valenti
- Dipartimento Scienze della Vita e dell'Ambiente, Sezione Scienze del Farmaco, Università degli Studi di Cagliari, Via Ospedale 72, 09124 Cagliari, Italy
| | - Valeria La Parola
- Istituto per lo Studio dei Materiali Nanostrutturati (ISMN), U.O.S. Palermo, CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy
| | - Serena Di Vincenzo
- Istituto di Biomedicina e Immunologia Molecolare (IBIM), CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy
| | - Mark Gjomarkaj
- Istituto di Biomedicina e Immunologia Molecolare (IBIM), CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy
| | - Gaetano Giammona
- Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy
| | - Maria Luisa Bondì
- Istituto per lo Studio dei Materiali Nanostrutturati (ISMN), U.O.S. Palermo, CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy
| | - Elisabetta Pace
- Istituto di Biomedicina e Immunologia Molecolare (IBIM), CNR, Via Ugo La Malfa, 153, 90146 Palermo, Italy.
| |
Collapse
|
217
|
Roh YG, Shin SW, Kim SY, Kim S, Lim YT, Oh BK, Um SH. Protein Nanoparticle Fabrication for Optimized Reticuloendothelial System Evasion and Tumor Accumulation. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2019; 35:3992-3998. [PMID: 30844286 DOI: 10.1021/acs.langmuir.8b03776] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Nanoparticles (NPs) of protein-based materials have become one of the most promising candidates for drug carriers in drug-delivery systems because of their in vivo nontoxicity, biodegradability, compatibility with hydrophilic drugs, and adaptability to the human body. Many studies have investigated the fabrication of protein NPs from human serum albumin (HSA) as a new drug carrier. It is important for these NPs to remain in the blood until they reach their therapeutic target to achieve the desired effect; the quicker the clearance of drugs from the body, the shorter is the residence time of drugs in the body, which eventually reduces drug efficacy. Macrophage uptake is a major mechanism for clearance of NPs from the body, so, reducing the degree of macrophage uptake is a major challenge in drug-delivery systems. Original studies of HSA NP uptake by macrophages showed that denatured HSA and HSA NPs synthesized with 80% (v/v) ethanol showed a high degree of macrophage uptake. We found that HSA NPs synthesized with lower ethanol content at pH 7 showed lower macrophage uptake in in vitro macrophage cellular uptake experiments. The effects of the preparation parameters of ethanol concentration, pH, and glutaraldehyde on the macrophage uptake of NPs were thoroughly studied. This newly developed protein NP with lower macrophage uptake has potential application as a drug carrier for many delivery systems.
Collapse
Affiliation(s)
| | | | | | | | | | - Byung-Keun Oh
- Department of Chemical and Biomolecular Engineering , Sogang University , Seoul 121-742 , South Korea
| | | |
Collapse
|
218
|
Yang P, Dong Y, Huang D, Zhu C, Liu H, Pan X, Wu C. Silk fibroin nanoparticles for enhanced bio-macromolecule delivery to the retina. Pharm Dev Technol 2019; 24:575-583. [PMID: 30457420 DOI: 10.1080/10837450.2018.1545236] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The aim of this study was to investigate intravitreal injection of silk fibroin nanoparticles (SFNs) encapsulating bio-macromolecules, achieving enhanced drug bioavailability, and extended retention in retina. SFNs were prepared with regenerated silk fibroin using desolvation method with fluorescein isothiocyanate labeled bovine serum albumin (FITC-BSA) as bio-macromolecular model drug encapsulated. In vitro physicochemical properties and in vitro drug release of FITC-BSA loaded SFNs (FITC-BSA-SFNs) were evaluated. Cytotoxicity, cellular uptake, and retention of FITC-BSA-SFNs were determined in human retinal pigment epithelial cell line (ARPE-19). In addition, in vivo distribution and safety of intravitreally administered FITC-BSA-SFNs were investigated in New Zealand white rabbits. The particle size of FITC-BSA-SFNs was 179.1 ± 3.7 nm with polydispersity index of 0.102 ± 0.033 and the zeta potential was greater than -25 mV. FITC-BSA-SFNs exhibited excellent biocompatibility with no cytotoxicity observed within 24 and 48 h in AREP-19 cells. Compared to FITC-BSA solution, FITC-BSA-SFNs showed enhanced cellular uptake and prolonged retention. Furthermore, FITC-BSA-SFNs achieved accumulated distribution and extended retention in retina in vivo following intravitreal injection compared to a single administration of free drug solution. Therefore, this bio-macromolecule delivery platform based on SFNs could have great potential in the treatment of posterior segment disorders.
Collapse
Affiliation(s)
- Pianpian Yang
- a School of Pharmaceutical Sciences , Sun Yat-Sen University , Guangzhou , China
| | - Yixuan Dong
- a School of Pharmaceutical Sciences , Sun Yat-Sen University , Guangzhou , China
| | - Di Huang
- a School of Pharmaceutical Sciences , Sun Yat-Sen University , Guangzhou , China
| | - Chune Zhu
- b Institute for Biomedical and Pharmaceutical Sciences , Guangdong University of Technology , Guangzhou , China
| | - Hu Liu
- c School of Pharmacy , Memorial University of Newfoundland , St. John's , NF , Canada
| | - Xin Pan
- a School of Pharmaceutical Sciences , Sun Yat-Sen University , Guangzhou , China
| | - Chuanbin Wu
- a School of Pharmaceutical Sciences , Sun Yat-Sen University , Guangzhou , China
| |
Collapse
|
219
|
Busi A, Aluigi A, Guerrini A, Boga C, Sartor G, Calonghi N, Sotgiu G, Posati T, Corticelli F, Fiori J, Varchi G, Ferroni C. Unprecedented Behavior of (9 R)-9-Hydroxystearic Acid-Loaded Keratin Nanoparticles on Cancer Cell Cycle. Mol Pharm 2019; 16:931-942. [PMID: 30702899 DOI: 10.1021/acs.molpharmaceut.8b00827] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Histone deacetylases, HDACs, have been demonstrated to play a critical role in epigenetic signaling and were found to be overexpressed in several type of cancers; therefore, they represent valuable targets for anticancer therapy. 9-Hydroxystearic acid has been shown to bind the catalytic site of HDAC1, inducing G0/G1 phase cell cycle arrest and activation of the p21WAF1 gene, thus promoting cell growth inhibition and differentiation in many cancer cells. Despite the ( R) enantiomer of 9-hydroxystearic acid (9R) displaying a promising in vitro growth-inhibitory effect on the HT29 cell line, its scarce water solubility and micromolar activity require novel solutions for improving its efficacy and bioavailability. In this work, we describe the synthesis and in vitro biological profiling of 9R keratin nanoparticles (9R@ker) obtained through an in-water drug-induced aggregation process. The anticancer activity of 9R@ker was investigated in the HT29 cell line; the results indicate an increased fluidity of cell membrane and a higher intracellular ROS formation, resulting in an unexpected S phase cell cycle arrest (25% increase as compared to the control) induced by 9R@ker with respect to free 9R and an induction of cell death.
Collapse
Affiliation(s)
- Alberto Busi
- Department of Industrial Chemistry , University of Bologna , Viale Risorgimento 4 , 40136 Bologna , Italy
| | - Annalisa Aluigi
- Institute for the Organic Synthesis and Photoreactivity, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| | - Andrea Guerrini
- Institute for the Organic Synthesis and Photoreactivity, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| | - Carla Boga
- Department of Industrial Chemistry , University of Bologna , Viale Risorgimento 4 , 40136 Bologna , Italy
| | - Giorgio Sartor
- Department of Pharmacy and Biotechnology , University of Bologna , Via Irnerio 48 , 40126 Bologna , Italy
| | - Natalia Calonghi
- Department of Pharmacy and Biotechnology , University of Bologna , Via Irnerio 48 , 40126 Bologna , Italy
| | - Giovanna Sotgiu
- Institute for the Organic Synthesis and Photoreactivity, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| | - Tamara Posati
- Institute for the Organic Synthesis and Photoreactivity, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| | - Franco Corticelli
- Institute for Microelectronics and Microsystems, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| | - Jessica Fiori
- Department of Chemistry "G. Ciamician" , University of Bologna , Via Selmi 2 , 40126 Bologna , Italy
| | - Greta Varchi
- Institute for the Organic Synthesis and Photoreactivity, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| | - Claudia Ferroni
- Institute for the Organic Synthesis and Photoreactivity, National Research Council , Via Gobetti 101 , 40129 Bologna , Italy
| |
Collapse
|
220
|
Reed NA, Raliya R, Tang R, Xu B, Mixdorf M, Achilefu S, Biswas P. Electrospray Functionalization of Titanium Dioxide Nanoparticles with Transferrin for Cerenkov Radiation Induced Cancer Therapy. ACS APPLIED BIO MATERIALS 2019; 2:1141-1147. [PMID: 31214665 DOI: 10.1021/acsabm.8b00755] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Titanium dioxide (TiO2) nanoparticles have shown success as photosensitizers in the form of light-based cancer therapy called Cerenkov radiation induced therapy (CRIT). While TiO2 nanoparticles have been reported to be an effective therapeutic agent, there has been little work to control their functionalization and stability in aqueous suspension. In this work, the controlled coating of 25 nm diameter TiO2 nanoparticles with the glycoprotein transferrin (Tf) for application in CRIT was demonstrated using an electrospray system. Monodisperse nanoscale droplets containing TiO2 and Tf were dried during flight, coating the proteins on the surface of the metal oxide nanoparticles. Real-time scanning mobility particle sizing, dynamic light scattering, and transmission electron microscopy show efficient control of the Tf coating thickness when varying the droplet size and the ratio of Tf to TiO2 in the electrospray precursor suspension. Further, the functionality of Tf-coated TiO2 nanoparticles was demonstrated, and these particles were found to have enhanced targeting activity of Tf to the Tf receptor after electrospray processing. The electrospray-coated Tf/TiO2 particles were also found to be more effective at killing the multiple myeloma cell line MM1.S than that of nanoparticles prepared by other reported functionalization methods. In summary, this investigation not only provides a single-step functionalization technique for nanomaterials used in Cerenkov radiation induced therapy but also elucidates an electrospray coating technique for nanomaterials that can be used for a wide range of drug design and delivery purposes.
Collapse
Affiliation(s)
- Nathan A Reed
- Aerosol and Air Quality Research Laboratory, Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States
| | - Ramesh Raliya
- Aerosol and Air Quality Research Laboratory, Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States
| | - Rui Tang
- Optical Radiology Lab, Mallinckrodt Institute of Radiology, Department of Radiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States
| | - Baogang Xu
- Optical Radiology Lab, Mallinckrodt Institute of Radiology, Department of Radiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States
| | - Matthew Mixdorf
- Optical Radiology Lab, Mallinckrodt Institute of Radiology, Department of Radiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States
| | - Samuel Achilefu
- Optical Radiology Lab, Mallinckrodt Institute of Radiology, Department of Radiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States.,Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States.,Department of Biochemistry and Molecular Biophysics, School of Medicine, Washington University in St. Louis, St. Louis, Missouri 63130, United States
| | - Pratim Biswas
- Aerosol and Air Quality Research Laboratory, Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States
| |
Collapse
|
221
|
Karimi A, Erfan M, Mortazavi SA, Ghorbani-Bidkorbeh F, Kobarfard F, Shirazi FH. Functionalisation of carbon nanotubes by methotrexate and study of synchronous photothermal effect of carbon nanotube and anticancer drug on cancer cell death. IET Nanobiotechnol 2019; 13:52-57. [PMID: 30964038 PMCID: PMC8676457 DOI: 10.1049/iet-nbt.2018.5085] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2017] [Revised: 06/29/2018] [Accepted: 07/19/2018] [Indexed: 01/16/2023] Open
Abstract
Carboxylated functionalised multi-walled carbon nanotubes (f-MWCNT) were synthesised. Furthermore, folic acid (FA) and methotrexate (MTX) through ethylenediamine (ED) were attached to the surface of f-MWCNT to synthesise MWCNT-ED-FA and MWCNT-ED-MTX. Release studies of MTX as free drug and in MWCNT-ED-MTX were performed. These studies showed that MTX release rate from MWCNT-ED-MTX decreased in comparison with free MTX, which is due to the MTX attachment on the MWCNT. The anticancer effect of MWCNT-ED-FA and MWCNT-ED-MTX on the breast cancer cell line (MCF-7) was studied. Studies have shown that MWCNT-ED-MTX cytotoxicity is more than that of MWCNT-ED-FA, which is due to the presence of MTX. Furthermore, the anticancer effects of MWCNT-ED-FA and MWCNT-ED-MTX in the presence of infrared laser radiation on the MCF7 cell were studied. The experiments showed that in the presence of the laser, the cytotoxicities of MWCNT-ED-FA and MWCNT-ED-MTX were the same and increased in comparison with laser absence, which indicates that the photothermal effect is stronger than other factors and mask their effects. This effect can be related to laser radiation absorption by MWCNT and its conversion to heat which can induce cancer cell death. Targeting studies have shown that MWCNT-ED-FA is targeted to the cancer cells due to the presence of FA.
Collapse
Affiliation(s)
- Ali Karimi
- Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mohammad Erfan
- Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Seyed Alireza Mortazavi
- Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| | - Fatemeh Ghorbani-Bidkorbeh
- Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Farzad Kobarfard
- Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Farshad H Shirazi
- Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
222
|
Pal A, Kumar Bajpai A, Bajpai J. Study on facile designing, swelling properties and structural relationship of gelatin nanoparticles. JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY 2019. [DOI: 10.1080/10601325.2019.1565542] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Anjali Pal
- Bose Memorial Research Laboratory, Department of Chemistry, Govt. Autonomous Science College, Jabalpur, M.P., India
| | - Anil Kumar Bajpai
- Bose Memorial Research Laboratory, Department of Chemistry, Govt. Autonomous Science College, Jabalpur, M.P., India
| | - Jaya Bajpai
- Bose Memorial Research Laboratory, Department of Chemistry, Govt. Autonomous Science College, Jabalpur, M.P., India
| |
Collapse
|
223
|
Mirmohseni F, Cheng T, Oveissi F, Behi M, Schindeler A, Little D, Naficy S, Dehghani F, Valtchev P. Optimized Synthesis of Poly(deoxyribose) Isobutyrate, a Viscous Biomaterial for Bone Morphogenetic Protein-2 Delivery. ACS APPLIED MATERIALS & INTERFACES 2019; 11:2870-2879. [PMID: 30589525 DOI: 10.1021/acsami.8b20126] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Injectable and phase-transitioning carriers from natural polysaccharides have great potential for the minimally invasive delivery of therapeutic proteins in the field of bone tissue engineering. In this study, a novel and highly viscous drug carrier was synthesized by a sequential process of deoxyribose polycondensation and esterification. The effect of synthesis parameters on the molecular weight, viscosity, and adhesion of the material was studied and correlated to temperature and time of polycondensation ( Tp and tp), time and temperature of esterification ( Te and te), and the molar ratio of the monomer ( R). The formulations were evaluated for molecular weight and distribution properties using GPC, chemical structures by FTIR and NMR spectra, and rheological properties using a rheometer. Formulations illustrated a wide range of viscosities (0.736 to 2225 Pa s), adhesion (0.896 to 58.45 N), and molecular weights (637 to 4216 Da), where viscosity was significantly reduced in the presence of low amounts of solvents (10-20%). The sustained release of BSA was observed over 42 days in vitro. The biocompatibility of poly(deoxyribose) isobutyrate (PDIB) as well as its potential as a bone morphogenetic protein delivery system was assessed in vivo using a rat ectopic bone model, where bone nodules were observed at 2 weeks. In summary, PDIB is a promising molecule with multiple applications for protein delivery, including for bone tissue engineering.
Collapse
Affiliation(s)
- Farid Mirmohseni
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| | | | - Farshad Oveissi
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| | - Mohammadreza Behi
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| | - Aaron Schindeler
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| | | | - Sina Naficy
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| | - Fariba Dehghani
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| | - Peter Valtchev
- School of Chemical and Biomolecular Engineering , The University of Sydney , Sydney 2006 , Australia
| |
Collapse
|
224
|
Karaca N, Ünlüer ÖB. Albumin Based Nanoparticles for Detection of Pancreatic Cancer Cells. Protein Pept Lett 2019; 26:271-280. [PMID: 30659529 DOI: 10.2174/0929866526666190119121434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Revised: 12/13/2018] [Accepted: 01/03/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Molecular imaging of cancer cells using effective drug targeting systems are most interested research area in recent years. Albumin protein is a soluble and most abundant protein in circulatory system. It has a ligand-binding function and acts as a transport protein. Researchers are interested in developing albumin based nanostructured specific anti-tumor drugs in cancer therapy. Pancreatic cancer treatment or drug design for targeted pancreatic cancer cell has great importance due to it has a high mortality rate comparing other cancer types. OBJECTIVE In this article, our goal is to develop new targeting nanoparticles based on the conjugation of albumin and Hyaluronic Acid (HA) for pancreatic cancer cells. METHOD In this article, we proposed a new technique for conjugation of albumin (BSA) and HA in nano formation. Firstly, cationic BSA is synthesized. Then, BSA-HA conjugation is obtained by interacted cationic BSA with 1000 ppm HA. Secondly, nano BSA-HA particles and nano BSA particles were synthesized according to AmiNoAcid Decorated and Light Underpinning Conjugation Approach (ANADOLUCA) method which provides a special cross-linking strategy for biomolecules using ruthenium-based amino acid monomer haptens. After characterization studies, in vitro cytotoxic activity of synthesized nano BSA-HA particles were determined for PANC-1 ATCC® CRL146 cells. RESULTS According to the data, nano BSA and nano BSA-HA particles synthesized uniquely using special ruthenium-based amino acid decorated cross-linking agent, (MATyr)2-Ru-(MATyr)2.based on ANDOLUCA method. Characterization results showed that there was not any change in protein folding structures during nano formation process. In addition, nano protein particles gained fluorescence feature. When interacting synthesized nano BSA and nano BSA-HA particles with pancreatic cells, it was found that BSA nanoparticles were usually around cells and membranes, but BSA-HA nanoparticles were identified around the cells, in the cytoplasm inside the cell, and next to the cell nucleus. So, nano BSA-HA particles could be used as cancer cell imaging agent for PANC-1 ATCC® CRL146 cells. CONCLUSION The satisfactory conclusion of this study is that synthesized nano BSA-HA particles are fundamental materials for targeting pancreatic cancer cells due to HA receptors located on pancreatic cancer cells and imaging agents due to fluorescence feature of the BSA-HA nanoparticles.
Collapse
Affiliation(s)
- Nursenem Karaca
- Graduate School of Health Sciences, Department of Pharmacognosy, Anadolu University, Eskisehir, Turkey
| | - Özlem Biçen Ünlüer
- Department of Chemistry, Faculty of Science, Eskisehir Technical University , Eskisehir, Turkey
| |
Collapse
|
225
|
Motevalli SM, Eltahan AS, Liu L, Magrini A, Rosato N, Guo W, Bottini M, Liang XJ. Co-encapsulation of curcumin and doxorubicin in albumin nanoparticles blocks the adaptive treatment tolerance of cancer cells. BIOPHYSICS REPORTS 2019. [DOI: 10.1007/s41048-018-0079-6] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
226
|
Prabakaran S, Jeyaraj M, Nagaraj A, Sadasivuni KK, Rajan M. Polymethyl methacrylate–ovalbumin @ graphene oxide drug carrier system for high anti-proliferative cancer drug delivery. APPLIED NANOSCIENCE 2019. [DOI: 10.1007/s13204-019-00950-5] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
227
|
Li Y, Wang X, Yan J, Liu Y, Yang R, Pan D, Wang L, Xu Y, Li X, Yang M. Nanoparticle ferritin-bound erastin and rapamycin: a nanodrug combining autophagy and ferroptosis for anticancer therapy. Biomater Sci 2019; 7:3779-3787. [DOI: 10.1039/c9bm00653b] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
The intracellular autophagy-mediated ferroptosis-induction process by the NFER nanodrug assembled by ferritin, erastin, and rapamycin.
Collapse
|
228
|
Formation and characterization of self-assembled bovine serum albumin nanoparticles as chrysin delivery systems. Colloids Surf B Biointerfaces 2019; 173:43-51. [DOI: 10.1016/j.colsurfb.2018.09.046] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2018] [Revised: 08/24/2018] [Accepted: 09/20/2018] [Indexed: 12/20/2022]
|
229
|
Zhu XJ, Li RF, Xu L, Yin H, Chen L, Yuan Y, Zhong W, Lin J. A Novel Self-Assembled Mitochondria-Targeting Protein Nanoparticle Acting as Theranostic Platform for Cancer. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2019; 15:e1803428. [PMID: 30450734 DOI: 10.1002/smll.201803428] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Revised: 10/31/2018] [Indexed: 06/09/2023]
Abstract
Self-assembled protein nanoparticles have attracted much attention in biomedicine because of their biocompatibility and biodegradability. Protein nanoparticles have become widely utilized as diagnostic or therapeutic agents for various cancers. However, there are no reports that protein nanoparticles can specifically target mitochondria. This targeting is desirable, since mitochondria are critical in the development of cancer cells. In this study, the discovery of a novel self-assembled metal protein nanoparticle, designated GST-MT-3, is reported, which targets the mitochondria of cancer cells within 30 min in vitro and rapidly accumulates in tumors within 1 h in vivo. The nanoparticles chelate cobalt ions [GST-MT-3(Co2+ )], which induces reactive oxygen species (ROS) production and reduces the mitochondrial membrane potential. These effects lead to antitumor activity in vivo. GST-MT-3(Co2+ ) with covalently conjugated paclitaxel synergistically suppress tumors and prolong survival. Importantly, the effective dosage of paclitaxel is 50-fold lower than that utilized in standard chemotherapy (0.2 vs 10 mg kg-1 ). To the best of the authors' knowledge, GST-MT-3 is the first reported protein nanoparticle that targets mitochondria. It has the potential to be an excellent platform for combination therapies.
Collapse
Affiliation(s)
- Xin-Jie Zhu
- Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Innovation Center for Genomics, Peking University, Beijing, 100871, China
| | - Ri-Fei Li
- State Key Laboratory of Agrobiotechnology and College of Veterinary Medicine, China Agricultural University, Beijing, 100094, China
| | - Liang Xu
- Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Innovation Center for Genomics, Peking University, Beijing, 100871, China
| | - Hui Yin
- Department of Radiology, Clinical College of 307th Hospital of PLA, Anhui Medical University, 307 Hospital, PLA, Beijing, 100071, China
| | - Long Chen
- Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Innovation Center for Genomics, Peking University, Beijing, 100871, China
| | - Ye Yuan
- Beijing Institute of Pharmacology and Toxicology, National Beijing Center for Drug Safety Evaluation and Research, State Key Laboratory of Toxicology and Medical Countermeasures, Academy of Military Medical Sciences, Beijing, 100850, China
| | - Wu Zhong
- Beijing Institute of Pharmacology and Toxicology, National Beijing Center for Drug Safety Evaluation and Research, State Key Laboratory of Toxicology and Medical Countermeasures, Academy of Military Medical Sciences, Beijing, 100850, China
| | - Jian Lin
- Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Innovation Center for Genomics, Peking University, Beijing, 100871, China
| |
Collapse
|
230
|
Kumar V, Choudhary AK, Kumar P, Sharma S. Nanotechnology: Nanomedicine, Nanotoxicity and Future Challenges. ACTA ACUST UNITED AC 2018. [DOI: 10.2174/2210681208666180125143953] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Introduction:
This review gives an overview of interesting properties of nanoparticles
finding potential applications in nanomedicines and their considerations that need to be made such
as toxicity while developing a nanomedicine by providing an understanding of a relationship between
nanocarrier, targeting moieties and drugs with optical and magnetic properties. Here, we correlate
the interesting properties of nanomaterials to their applications in living cells/body simultaneously
promises, prospects and toxicity challenges of nanomedicines have also been discussed in
detail. Exemplifying the usage of gold nanoparticles and its derivatives such as hetero and homo
hybrid nanostructures that allow their use as contrast agents, therapeutic entities and supports to attach
functional molecules and targeting ligand along with molecular framework structures. Here,
we present the future prospects for potential applications in nanomedicines. These nanomaterials
have been used for varieties of biomedical applications such as targeted drug delivery, photothermal
cancer therapies, MRI, optical imaging, etc. in vitro and in vivo.
Conclusion:
In summary, this review provides innumerable aspects in the emerging field of
nanomedicine and possible nanotoxicity.
Collapse
Affiliation(s)
- Vinod Kumar
- Department of Chemistry, Kirori Mal College, University of Delhi, Delhi-110007, India
| | | | - Prashant Kumar
- Metallurgical Engineering and Materials Science Department, Indian Institute of Technology Bombay, Powai, Mumbai-400076, Maharashtra, India
| | - Saurabh Sharma
- Department of Chemistry, Kirori Mal College, University of Delhi, Delhi-110007, India
| |
Collapse
|
231
|
Chen H, Gu Z, An H, Chen C, Chen J, Cui R, Chen S, Chen W, Chen X, Chen X, Chen Z, Ding B, Dong Q, Fan Q, Fu T, Hou D, Jiang Q, Ke H, Jiang X, Liu G, Li S, Li T, Liu Z, Nie G, Ovais M, Pang D, Qiu N, Shen Y, Tian H, Wang C, Wang H, Wang Z, Xu H, Xu JF, Yang X, Zhu S, Zheng X, Zhang X, Zhao Y, Tan W, Zhang X, Zhao Y. Precise nanomedicine for intelligent therapy of cancer. Sci China Chem 2018. [DOI: 10.1007/s11426-018-9397-5] [Citation(s) in RCA: 279] [Impact Index Per Article: 46.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
232
|
Hiremath CG, Kariduraganavar MY, Hiremath MB. Synergistic delivery of 5-fluorouracil and curcumin using human serum albumin-coated iron oxide nanoparticles by folic acid targeting. Prog Biomater 2018; 7:297-306. [PMID: 30565175 PMCID: PMC6304179 DOI: 10.1007/s40204-018-0104-3] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Accepted: 12/11/2018] [Indexed: 01/24/2023] Open
Abstract
Human serum albumin is the most abundant protein in plasma with the ability to bind to a variety of drug molecules. Magnetic nanoparticles are being extensively used in drug delivery due to its intrinsic magnetic properties. In this work, we have synthesized human serum albumin-coated citrate-functionalized iron oxide nanoparticles by CDI coupling. Furthermore, folic acid was decorated on human serum albumin by EDC and NHS coupling to confer targetability. Two cytotoxic drugs 5-fluorouracil (5FU) and curcumin were co-delivered. Wherein, the former is an anticancer agent and latter is a drug resistance depressor of former. The nanoparticles showed good aqueous dispersibility with a zeta potential of - 49.1 mV and magnetic core size in the range of 10-15 nm, thus exhibiting good magnetic property with magnetic saturation of 33.59 emu/g. Controlled drug release behavior was noticed in both drugs with faster release profile of 5FU. Nanoparticles also showed good cytotoxicity with lower IC50 values in the presence of magnetic field. The contrasting difference was noticed in folic acid-decorated and non-decorated composites, similarly in the presence of magnetic field where cell uptake was enhanced.
Collapse
Affiliation(s)
- Chinmay G. Hiremath
- Department of Biotechnology and Microbiology, Karnatak University, Dharwad, Karnataka 580003 India
| | | | - Murigendra B. Hiremath
- Department of Biotechnology and Microbiology, Karnatak University, Dharwad, Karnataka 580003 India
| |
Collapse
|
233
|
Ferreres G, Bassegoda A, Hoyo J, Torrent-Burgués J, Tzanov T. Metal-Enzyme Nanoaggregates Eradicate Both Gram-Positive and Gram-Negative Bacteria and Their Biofilms. ACS APPLIED MATERIALS & INTERFACES 2018; 10:40434-40442. [PMID: 30388361 DOI: 10.1021/acsami.8b14949] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
To palliate the appearance of antimicrobial resistance (AMR), the use of bactericidal agents acting differently than conventional antibiotics and the elimination of bacterial biofilm, are the two most promising strategies. Here, we integrated these two complementary strategies into new antimicrobial metal-enzyme nanoaggregates (NAs) of α-amylase and silver (αAgNAs) that are able to eliminate bacteria and their biofilm. The nanoparticle (NP) synthesis approach applied protein desolvation and laccase-mediated NP stabilization to innovatively produce catalytically active α-amylase nanoparticles (αNPs) for the elimination of the bacterial biofilm. At the same time, αNPs efficiently reduced silver for the incorporation of bactericidal Ag0 and formation of the αAgNAs. The bactericidal and antibiofilm efficacies of αAgNAs were demonstrated by 5.4 and 6.1 log reduction of Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli, respectively, and more than 80% removal of their biofilms, coupled with high biocompatibility. The biofilm-αAgNA interaction was assessed by quartz crystal microbalance and atomic force microscopy revealing how the degradation of a settled biofilm by αAgNAs caused an increase of the biofilm water content, thus weakening the biofilm surface attachment and facilitating its removal. With the present work, we not only provide a new efficient antimicrobial material to face the AMR threat, but we also envisage that the newly established method for the synthesis of metal-enzyme NAs is potentially transferable to other biocatalysts to expand the enzyme NP toolbox.
Collapse
Affiliation(s)
- Guillem Ferreres
- Grup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering , Universitat Politècnica de Catalunya , Rambla Sant Nebridi 22 , Terrassa 08222 , Spain
| | - Arnau Bassegoda
- Grup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering , Universitat Politècnica de Catalunya , Rambla Sant Nebridi 22 , Terrassa 08222 , Spain
| | - Javier Hoyo
- Grup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering , Universitat Politècnica de Catalunya , Rambla Sant Nebridi 22 , Terrassa 08222 , Spain
| | - Juan Torrent-Burgués
- Grup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering , Universitat Politècnica de Catalunya , Rambla Sant Nebridi 22 , Terrassa 08222 , Spain
| | - Tzanko Tzanov
- Grup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering , Universitat Politècnica de Catalunya , Rambla Sant Nebridi 22 , Terrassa 08222 , Spain
| |
Collapse
|
234
|
Delavari B, Mamashli F, Bigdeli B, Poursoleiman A, Karami L, Zolmajd-Haghighi Z, Ghasemi A, Samaei-Daryan S, Hosseini M, Haertlé T, Muronetz VI, Halskau Ø, Moosavi-Movahedi AA, Goliaei B, Rezayan AH, Saboury AA. A biophysical study on the mechanism of interactions of DOX or PTX with α-lactalbumin as a delivery carrier. Sci Rep 2018; 8:17345. [PMID: 30478403 PMCID: PMC6255783 DOI: 10.1038/s41598-018-35559-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 11/07/2018] [Indexed: 01/25/2023] Open
Abstract
Doxorubicin and paclitaxel, two hydrophobic chemotherapeutic agents, are used in cancer therapies. Presence of hydrophobic patches and a flexible fold could probably make α-Lactalbumin a suitable carrier for hydrophobic drugs. In the present study, a variety of thermodynamic, spectroscopic, computational, and cellular techniques were applied to assess α-lactalbumin potential as a carrier for doxorubicin and paclitaxel. According to isothermal titration calorimetry data, the interaction between α-lactalbumin and doxorubicin or paclitaxel is spontaneous and the K (M-1) value for the interaction of α-lactalbumin and paclitaxel is higher than that for doxorubicin. Differential scanning calorimetry and anisotropy results indicated formation of α-lactalbumin complexes with doxorubicin or paclitaxel. Furthermore, molecular docking and dynamic studies revealed that TRPs are not involved in α-Lac's interaction with Doxorubicin while TRP 60 interacts with paclitaxel. Based on Pace analysis to determine protein thermal stability, doxorubicin and paclitaxel induced higher and lower thermal stability in α-lactalbumin, respectively. Besides, fluorescence lifetime measurements reflected that the interaction between α-lactalbumin with doxorubicin or paclitaxel was of static nature. Therefore, the authors hypothesized that α-lactalbumin could serve as a carrier for doxorubicin and paclitaxel by reducing cytotoxicity and apoptosis which was demonstrated during our in vitro cell studies.
Collapse
Affiliation(s)
- Behdad Delavari
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran.,Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran
| | - Fatemeh Mamashli
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Bahareh Bigdeli
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Atefeh Poursoleiman
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Leila Karami
- Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
| | - Zahra Zolmajd-Haghighi
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Atiyeh Ghasemi
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Samaneh Samaei-Daryan
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Morteza Hosseini
- Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran
| | - Thomas Haertlé
- Poznań University of Life Sciences, Department of Animal Nutrition and Feed Management, Poznań, Poland.,UR 1268 Biopolymères Interactions Assemblages, INRA, B.P. 71627, 44316, Nantes, Cedex 3, France
| | - Vladimir I Muronetz
- Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119234, Moscow, Russia
| | - Øyvind Halskau
- Department of Molecular Biology, University of Bergen, PB 7803, N-5020, Bergen, Norway
| | | | - Bahram Goliaei
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran
| | - Ali Hossein Rezayan
- Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran
| | - Ali Akbar Saboury
- Institute of Biochemistry and Biophysics, University of Tehran, Mailbox, 13145-1384, Tehran, Iran.
| |
Collapse
|
235
|
Hobernik D, Bros M. DNA Vaccines-How Far From Clinical Use? Int J Mol Sci 2018; 19:ijms19113605. [PMID: 30445702 PMCID: PMC6274812 DOI: 10.3390/ijms19113605] [Citation(s) in RCA: 290] [Impact Index Per Article: 48.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Revised: 11/07/2018] [Accepted: 11/09/2018] [Indexed: 12/12/2022] Open
Abstract
Two decades ago successful transfection of antigen presenting cells (APC) in vivo was demonstrated which resulted in the induction of primary adaptive immune responses. Due to the good biocompatibility of plasmid DNA, their cost-efficient production and long shelf life, many researchers aimed to develop DNA vaccine-based immunotherapeutic strategies for treatment of infections and cancer, but also autoimmune diseases and allergies. This review aims to summarize our current knowledge on the course of action of DNA vaccines, and which factors are responsible for the poor immunogenicity in human so far. Important optimization steps that improve DNA transfection efficiency comprise the introduction of DNA-complexing nano-carriers aimed to prevent extracellular DNA degradation, enabling APC targeting, and enhanced endo/lysosomal escape of DNA. Attachment of virus-derived nuclear localization sequences facilitates nuclear entry of DNA. Improvements in DNA vaccine design include the use of APC-specific promotors for transcriptional targeting, the arrangement of multiple antigen sequences, the co-delivery of molecular adjuvants to prevent tolerance induction, and strategies to circumvent potential inhibitory effects of the vector backbone. Successful clinical use of DNA vaccines may require combined employment of all of these parameters, and combination treatment with additional drugs.
Collapse
Affiliation(s)
- Dominika Hobernik
- Department of Dermatology, University Medical Center, 55131 Mainz, Germany.
| | - Matthias Bros
- Department of Dermatology, University Medical Center, 55131 Mainz, Germany.
| |
Collapse
|
236
|
Martins JT, Bourbon AI, Pinheiro AC, Fasolin LH, Vicente AA. Protein-Based Structures for Food Applications: From Macro to Nanoscale. FRONTIERS IN SUSTAINABLE FOOD SYSTEMS 2018. [DOI: 10.3389/fsufs.2018.00077] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
237
|
Jain A, Singh SK, Arya SK, Kundu SC, Kapoor S. Protein Nanoparticles: Promising Platforms for Drug Delivery Applications. ACS Biomater Sci Eng 2018; 4:3939-3961. [DOI: 10.1021/acsbiomaterials.8b01098] [Citation(s) in RCA: 114] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Annish Jain
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Chandigarh 160 014, India
| | - Sumit K. Singh
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Chandigarh 160 014, India
| | - Shailendra K. Arya
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Chandigarh 160 014, India
| | - Subhas C. Kundu
- 3B’s Research Group, I3Bs − Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, 4805-017 Barco, Guimarães, Portugal
| | - Sonia Kapoor
- Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Chandigarh 160 014, India
- Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida 201 313, Uttar Pradesh, India
| |
Collapse
|
238
|
Morozova OV, Pavlova ER, Bagrov DV, Barinov NA, Prusakov KA, Isaeva EI, Podgorsky VV, Basmanov DV, Klinov DV. Protein nanoparticles with ligand-binding and enzymatic activities. Int J Nanomedicine 2018; 13:6637-6646. [PMID: 30425479 PMCID: PMC6202000 DOI: 10.2147/ijn.s177627] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Purpose To develop a general method for NP fabrication from various proteins with maintenance of biological activity. Methods A novel general approach for producing protein nanoparticles (NP) by nanoprecipitation of the protein solutions in 1,1,1,3,3,3-hexafluoroisopropanol is described. Protein NP sizes and shapes were analyzed by dynamic light scattering, scanning electron and atomic force microscopy (SEM and AFM). Chemical composition of the NP was confirmed using ultraviolet (UV) spectroscopy, energy-dispersive X-ray spectroscopy (EDX) and circular dichroism (CD). Biological properties of the NP were analyzed in ELISA, immunofluorescent analysis and lysozyme activity assay. Results Water-insoluble NP were constructed from globular (bovine serum albumin (BSA), lysozyme, immunoglobulins), fibrillar (fibrinogen) proteins and linear polylysines by means of nanoprecipitation of protein solutions in fluoroalcohols. AFM and SEM revealed NP sizes of 20–250 nm. The NP chemical structure was confirmed by UV spectroscopy, protease digestion and EDX spectroscopy. CD spectra revealed a stable secondary structure of proteins in NP. The UV spectra, microscopy and SDS-PAA gel electrophoresis (PAGE) proved the NP stability at +4°C for 7 months. Co-precipitation of proteins with fluorophores or nanoprecipitation of pre-labeled BSA resulted in fluorescent NP that retained antigenic structures as shown by their binding with specific antibodies. Moreover, NP from monoclonal antibodies could bind with the hepatitis B virus antigen S. Besides that, lysozyme NP could digest bacterial cellular walls. Conclusion Thus, the water-insoluble, stable protein NP were produced by nanoprecipitation without cross-linking and retained ligand-binding and enzymatic activities.
Collapse
Affiliation(s)
- Olga V Morozova
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia, .,Ivanovsky Institute of Virology of the National Research Center of Epidemiology and Microbiology of N.F. Gamaleya of the Russian Ministry of Health, Moscow, Russia,
| | - Elizaveta R Pavlova
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia, .,Moscow Institute of Physics and Technology, Moscow, Russia
| | - Dmitry V Bagrov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia, .,Department of Bioengineering, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia
| | - Nikolay A Barinov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia,
| | - Kirill A Prusakov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia, .,Moscow Institute of Physics and Technology, Moscow, Russia
| | - Elena I Isaeva
- Ivanovsky Institute of Virology of the National Research Center of Epidemiology and Microbiology of N.F. Gamaleya of the Russian Ministry of Health, Moscow, Russia,
| | - Victor V Podgorsky
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia,
| | - Dmitry V Basmanov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia,
| | - Dmitry V Klinov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (FRCC PCM), Moscow, Russia,
| |
Collapse
|
239
|
Madugulla L, Ravula AR, Kondapi AK, Yenugu S. Evaluation of the reproductive toxicity of antiretroviral drug loaded lactoferrin nanoparticles. Syst Biol Reprod Med 2018; 65:205-213. [PMID: 30260720 DOI: 10.1080/19396368.2018.1519047] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Multiple prevention therapy has gained importance for the prevention and treatment of sexually transmitted diseases, especially HIV/AIDS. Antiretroviral drugs encapsulated in nanoparticles have been developed for efficient delivery of the drugs to the vaginal surface. Lactoferrin nanoparticles (LFNPs) encapsulating anticancer or antiretroviral drugs are found to be promising agents to specifically deliver drugs at the target sites. Recent studies indicate that the bioavailability is higher for antiretroviral drugs delivered by LFNPs than when the drugs are administered alone. Although LFNP-mediated drug delivery via the oral or vaginal route for the treatment of HIV/AIDS is promising, the effect of such administrations is not well studied. Drug-loaded LFNPs when administered to rats by the vaginal route did not show any effect on the reproductive performance, fertility, and postnatal development. Oral administration of drug-loaded LFNPs caused a significant decrease in litter size, whereas the reproductive performance and postnatal development remained normal. In our model system, the results indicate that vaginal administration of drug-loaded LFNPs appears safer and can be projected for the delivery of antiretroviral agents via the vaginal route. Abbreviations: LFNPs: lactoferrin nanoparticles; STIs: sexually transmitted diseases infections; NPs: nanoparticles; LF: lactoferrin; DL-LFNPs: drug loaded lactoferrin nanoparticles; MPT: multiple prevention techniques.
Collapse
Affiliation(s)
- Lavanya Madugulla
- a Department of Animal Biology, School of Life Sciences , University of Hyderabad , Hyderabad , India
| | - Anandha Rao Ravula
- a Department of Animal Biology, School of Life Sciences , University of Hyderabad , Hyderabad , India
| | - Anand Kumar Kondapi
- b Department of Biotechnology and Bioinformatics, School of Life Sciences , University of Hyderabad , Hyderabad , India
| | - Suresh Yenugu
- a Department of Animal Biology, School of Life Sciences , University of Hyderabad , Hyderabad , India
| |
Collapse
|
240
|
Stimuli-responsive, protein hydrogels for potential applications in enzymology and drug delivery$$^{\S }$$. J CHEM SCI 2018. [DOI: 10.1007/s12039-018-1538-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
241
|
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin HS. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 2018; 16:71. [PMID: 30231877 PMCID: PMC6145203 DOI: 10.1186/s12951-018-0392-8] [Citation(s) in RCA: 2658] [Impact Index Per Article: 443.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2018] [Accepted: 08/25/2018] [Indexed: 02/06/2023] Open
Abstract
Nanomedicine and nano delivery systems are a relatively new but rapidly developing science where materials in the nanoscale range are employed to serve as means of diagnostic tools or to deliver therapeutic agents to specific targeted sites in a controlled manner. Nanotechnology offers multiple benefits in treating chronic human diseases by site-specific, and target-oriented delivery of precise medicines. Recently, there are a number of outstanding applications of the nanomedicine (chemotherapeutic agents, biological agents, immunotherapeutic agents etc.) in the treatment of various diseases. The current review, presents an updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs (e.g., natural products) and selective diagnosis through disease marker molecules. The opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications are also discussed. In addition, we have included information regarding the trends and perspectives in nanomedicine area.
Collapse
Affiliation(s)
- Jayanta Kumar Patra
- Research Institute of Biotechnology & Medical Converged Science, Dongguk University-Seoul, Goyang-si, 10326 Republic of Korea
| | - Gitishree Das
- Research Institute of Biotechnology & Medical Converged Science, Dongguk University-Seoul, Goyang-si, 10326 Republic of Korea
| | - Leonardo Fernandes Fraceto
- Sao Paulo State University (UNESP), Institute of Science and Technology, Sorocaba, São Paulo Zip Code 18087-180 Brazil
- Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas, Campinas, São Paulo Zip code 13083-862 Brazil
| | - Estefania Vangelie Ramos Campos
- Sao Paulo State University (UNESP), Institute of Science and Technology, Sorocaba, São Paulo Zip Code 18087-180 Brazil
- Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas, Campinas, São Paulo Zip code 13083-862 Brazil
| | - Maria del Pilar Rodriguez-Torres
- Laboratorio de Investigación Interdisciplinaria, Área de Nanoestructuras y Biomateriales, Escuela Nacional de Estudios Superiores, Unidad Leon, Universidad Nacional Autonóma de México (UNAM), Boulevard UNAM No 2011. Predio El Saucillo y El Potrero, 37684 León, Guanajuato Mexico
| | - Laura Susana Acosta-Torres
- Laboratorio de Investigación Interdisciplinaria, Área de Nanoestructuras y Biomateriales, Escuela Nacional de Estudios Superiores, Unidad Leon, Universidad Nacional Autonóma de México (UNAM), Boulevard UNAM No 2011. Predio El Saucillo y El Potrero, 37684 León, Guanajuato Mexico
| | | | - Renato Grillo
- Department of Physics and Chemistry, School of Engineering, São Paulo State University (UNESP), Ilha Solteira, SP 15385-000 Brazil
| | - Mallappa Kumara Swamy
- Department of Crop Science, Faculty of Agriculture, Universiti Putra Malaysia, 43400 Serdang, Selangor Malaysia
| | - Shivesh Sharma
- Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Allahabad, Uttar Pradesh 211004 India
| | - Solomon Habtemariam
- Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Medway Campus-Science, Grenville Building (G102/G107), Central Avenue, Chatham-Maritime, Kent, ME4 4TB UK
| | - Han-Seung Shin
- Department of Food Science and Biotechnology, Dongguk University, Ilsandong-gu, Goyang, Gyeonggi-do 10326 Republic of Korea
| |
Collapse
|
242
|
Pawar A, Thakkar S, Misra M. A bird's eye view of nanoparticles prepared by electrospraying: advancements in drug delivery field. J Control Release 2018; 286:179-200. [DOI: 10.1016/j.jconrel.2018.07.036] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Revised: 07/22/2018] [Accepted: 07/23/2018] [Indexed: 01/19/2023]
|
243
|
Protein moiety in oligochitosan modified vector regulates internalization mechanism and gene delivery: Polyplex characterization, intracellular trafficking and transfection. Carbohydr Polym 2018; 202:143-156. [PMID: 30286987 DOI: 10.1016/j.carbpol.2018.08.131] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2018] [Revised: 08/13/2018] [Accepted: 08/29/2018] [Indexed: 12/11/2022]
Abstract
Oligochitosan-modified proteins have gained attention as efficient non-viral vectors for gene delivery. However, little information exists if protein moieties can serve as an important role for internalization and endosome escape ability of the genetic material. To explore this issue, we designed two cationic oligochitosan-modified vectors that consist of different proteins, namely a hydrophobic plant protein (zein) and a hydrophilic animal protein (ovalbumin (OVA)) to deliver pDNA to epithelial cell line CHO-K1 and HEK 293 T. These cationic vectors were systematically characterized by molecular weight, infrared (IR) structural analysis, transmission electron microscopy (TEM) morphology, and surface charge. A remarkable impact of protein moieties was observed on physiochemical properties of the developed vectors. Oligochitosan-modified zein containing hydrophobic protein exhibited high buffering capacity and excellent DNA binding ability compared to the oligochitosan-modified OVA. The data on transfection in the presence of endocytic inhibitors indicated that the caveolae-mediated pathway (CvME) played a key role in the internalization of the zein-based polyplex. However, the OVA-based polyplex was internalized in CHO-K1 cells via CvME and in HEK 293 T cells via the lipid-mediated pathway. Moreover, oligochitosan-modified zein exhibited lower cytotoxicity, greater lysosomal escape ability, better plasmid stability, and better transfection efficiency than the oligochitosan-modified OVA. This study offers a facile procedure for the synthesis of cationic vectors and elucidates the relationship that exists between protein moieties and transfection activity, thus providing an alternative, non-viral platform for the gene delivery.
Collapse
|
244
|
Foglietta F, Spagnoli GC, Muraro MG, Ballestri M, Guerrini A, Ferroni C, Aluigi A, Sotgiu G, Varchi G. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models. Int J Nanomedicine 2018; 13:4847-4867. [PMID: 30214193 PMCID: PMC6122896 DOI: 10.2147/ijn.s159942] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
PURPOSE Taxanes are highly effective cytotoxic drugs for progressing breast cancer treatment. However, their poor solubility and high toxicity urge the development of innovative formulations of potential clinical relevance. MATERIALS AND METHODS By using a simple and straightforward aggregation method, we have generated paclitaxel (PTX) loaded in keratin nanoparticles (KER-NPs-PTX). Their activities were tested against human breast cancer MCF-7 and MDA MB 231 cell lines in conventional two-dimensional (2D) cultures and in a dynamic three-dimensional (3D) model with perfused bioreactor (p3D). Moreover, KER-NPs-PTX activity was compared to free PTX and to PTX loaded in albumin nanoparticles (HSA-NPs-PTX). Cell viability, induction of apoptosis, and gene expression analysis were used as readouts. RESULTS In 2D cultures, KER-NPs-PTX was able to inhibit tumor cell viability and to induce apoptosis similarly to PTX and HSA-NPs-PTX. In the p3D model, a lower sensitivity of tumor cells to treatments was observed. Importantly, only KER-NPs-PTX was able to induce a statistically significant increase in apoptotic cell percentages following 24 h treatment for MCF-7 (16.7±4.0 early and 11.3±4.9 late apoptotic cells) and 48 h treatment for MDA MB 231 (21.3±11.2 early and 10.5±1.8 late apoptotic cells) cells. These effects were supported, at least for MCF-7 cells, by significant increases in the expression of proapoptotic BAX gene (5.8±0.5) 24 h after treatment and of cleaved caspase 3 (CC3) protein. CONCLUSION KER-NPs-PTX, generated by a simple procedure, is characterized by high water solubility and enhanced PTX-loading ability, as compared to HSA-NPs-PTX. Most importantly, it appears to be able to exert effective anticancer activities on breast cancer cells cultured in 2D or in p3D models.
Collapse
Affiliation(s)
- Federica Foglietta
- Department of Drug Science & Technology, University of Torino, Torino, Italy
| | - Giulio C Spagnoli
- Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland,
- Institute of Translational Pharmacology, CNR, Rome, Italy,
| | - Manuele Giuseppe Muraro
- Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland,
| | - Marco Ballestri
- Institute for Organic Synthesis & Photoreactivity, National Research Council, Bologna, Italy,
| | - Andrea Guerrini
- Institute for Organic Synthesis & Photoreactivity, National Research Council, Bologna, Italy,
| | - Claudia Ferroni
- Institute for Organic Synthesis & Photoreactivity, National Research Council, Bologna, Italy,
| | - Annalisa Aluigi
- Institute for Organic Synthesis & Photoreactivity, National Research Council, Bologna, Italy,
| | - Giovanna Sotgiu
- Institute for Organic Synthesis & Photoreactivity, National Research Council, Bologna, Italy,
| | - Greta Varchi
- Institute for Organic Synthesis & Photoreactivity, National Research Council, Bologna, Italy,
| |
Collapse
|
245
|
Engineered nanomaterials and human health: Part 1. Preparation, functionalization and characterization (IUPAC Technical Report). PURE APPL CHEM 2018. [DOI: 10.1515/pac-2017-0101] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Abstract
Nanotechnology is a rapidly evolving field, as evidenced by the large number of publications on the synthesis, characterization, and biological/environmental effects of new nano-sized materials. The unique, size-dependent properties of nanomaterials have been exploited in a diverse range of applications and in many examples of nano-enabled consumer products. In this account we focus on Engineered Nanomaterials (ENM), a class of deliberately designed and constructed nano-sized materials. Due to the large volume of publications, we separated the preparation and characterisation of ENM from applications and toxicity into two interconnected documents. Part 1 summarizes nanomaterial terminology and provides an overview of the best practices for their preparation, surface functionalization, and analytical characterization. Part 2 (this issue, Pure Appl. Chem. 2018; 90(8): 1325–1356) focuses on ENM that are used in products that are expected to come in close contact with consumers. It reviews nanomaterials used in therapeutics, diagnostics, and consumer goods and summarizes current nanotoxicology challenges and the current state of nanomaterial regulation, providing insight on the growing public debate on whether the environmental and social costs of nanotechnology outweigh its potential benefits.
Collapse
|
246
|
Kayani Z, Bordbar AK, Firuzi O. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells. Biomed Pharmacother 2018; 107:945-956. [PMID: 30257407 DOI: 10.1016/j.biopha.2018.08.047] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Revised: 08/06/2018] [Accepted: 08/10/2018] [Indexed: 11/15/2022] Open
Abstract
Chemotherapy constitutes the main strategy in management of breast cancer (BC). Lack of specificity and high burden of adverse effects of chemotherapeutic agents remain the most important impediments to successful treatment of BC patients. Folate receptor α (FRα) could be very promising for therapeutic targeting in this type of cancer. In this study, ß-lactoglobulin nanoparticles (BNPs) conjugated with folic acid and loaded with doxorubicin (FDBNPs) were prepared. Various characterization techniques were applied to determine the size, polydispersity and doxorubicin loading of prepared FDBNPs in comparison with doxorubicin-loaded BNPs (DBNPs). The results showed that FDBNPs are 109.77 ± 2.80 nm in diameter with well dispersed and spherical shapes. The biodegradation of FDBNPs in the presence of trypsin enzyme and in PBS at different pH (4 and 7) was spectrophotometrically monitored and the results showed that the FDBNPs with encapsulation efficiency of 68.82%±1.76% could deliver doxorubicin at clinically relevant doses. Effects of DBNPs and FDBNPs against MCF-7 and MDA-MB-231, BC and triple negative BC (TNBC) cell lines, respectively, showed significant inhibition of cell proliferation as well as induction of apoptosis. Based on these findings, FDBNPs with facilitated drug release and targeted doxorubicin delivery capacities could have high therapeutic potential for BC and TNBC.
Collapse
Affiliation(s)
- Zahra Kayani
- Department of Biotechnology, Faculty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, 81746-73441, Iran
| | | | - Omidreza Firuzi
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, 71345-3388, Iran.
| |
Collapse
|
247
|
Rudramurthy GR, Swamy MK. Potential applications of engineered nanoparticles in medicine and biology: an update. J Biol Inorg Chem 2018; 23:1185-1204. [PMID: 30097748 DOI: 10.1007/s00775-018-1600-6] [Citation(s) in RCA: 71] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Accepted: 07/26/2018] [Indexed: 12/22/2022]
Abstract
Nanotechnology advancements have led to the development of its allied fields, such as nanoparticle synthesis and their applications in the field of biomedicine. Nanotechnology driven innovations have given a hope to the patients as well as physicians in solving the complex medical problems. Nanoparticles with a size ranging from 0.2 to 100 nm are associated with an increased surface to volume ratio. Moreover, the physico-chemical and biological properties of nanoparticles can be modified depending on the applications. Different nanoparticles have been documented with a wide range of applications in various fields of medicine and biology including cancer therapy, drug delivery, tissue engineering, regenerative medicine, biomolecules detection, and also as antimicrobial agents. However, the development of stable and effective nanoparticles requires a profound knowledge on both physico-chemical features of nanomaterials and their intended applications. Further, the health risks associated with the use of engineered nanoparticles needs a serious attention.
Collapse
Affiliation(s)
| | - Mallappa Kumara Swamy
- Department of Crop Science, Faculty of Agriculture, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
| |
Collapse
|
248
|
Wang LJ, Chang YC, Osmanson AT, Zhang J, Li L. Facile continuous production of soy peptide nanogels via nanoscale flash desolvation for drug entrapment. Int J Pharm 2018; 549:13-20. [PMID: 30031865 DOI: 10.1016/j.ijpharm.2018.07.044] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Revised: 07/12/2018] [Accepted: 07/19/2018] [Indexed: 10/28/2022]
Abstract
A facile continuous production of soy peptide nanogels was demonstrated using a multi-inlet vortex micromixer for the entrapment of active ingredients. The full flow regime in the micromixer was systematically studied to understand the flow impact on nanogel size, drug encapsulation efficiency and drug loading efficiency. Ibuprofen was chosen as a model drug to demonstrate encapsulation capability. The study showed that the nanogel size, drug encapsulation efficiency and drug loading efficiency did not alter significantly as long as the flow rates were in transition and turbulent regimes. The driving force behind the folding of peptides within the microenvironment is kinetic mixing with high flow rates, which dominates in comparison to molecular diffusion, nucleation, and growth. Moreover, the hydrophilic-lipophilic balance of the soy peptides determined the drug encapsulation efficiency and the drug loading efficiency, which did not vary much under different manufacturing parameters. Both characteristics are beneficial to mass production of drug-entrapped peptide. In a 50% water-ethanol mixture, the encapsulation efficiency achieved 70% and the drug loading efficiency was up to 25% in transition and turbulent flow regimes. This work opens the avenues to continuous production of drug-entrapped soy peptide nanogels using a multi-inlet vortex micromixer.
Collapse
Affiliation(s)
- Li-Ju Wang
- School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA
| | - Yu-Chung Chang
- School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA
| | - Allison T Osmanson
- School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA
| | - Jinwen Zhang
- School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA; Composite Materials and Engineering Center, Washington State University, Pullman, WA 99164, USA
| | - Lei Li
- School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA.
| |
Collapse
|
249
|
Casa DM, Scariot DB, Khalil NM, Nakamura CV, Mainardes RM. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity. Exp Parasitol 2018; 192:12-18. [PMID: 30026113 DOI: 10.1016/j.exppara.2018.07.003] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2018] [Revised: 06/21/2018] [Accepted: 07/14/2018] [Indexed: 12/28/2022]
Abstract
Cutaneous leishmaniasis is the most common form of leishmaniasis and the available chemotherapy causes serious side effects, justifying the search for new therapies. This study investigated the antileishmanial activity of bovine serum albumin (BSA) nanoparticles containing amphotericin B (AmB) against Leishmania amazonensis. The antiproliferative activity against promastigotes and amastigotes was assessed and the cytotoxicity was determined and compared to commercial AmB-deoxycholate (AmB-D). In vivo antileishmania activity was evaluated in murine cutaneous leishmaniasis model. BSA nanoparticles showed spherical shape, mean size about 180 nm, zeta potential of ≈ -45 mV and AmB encapsulation efficiency >95%. AmB-D was effective in promastigote and amastigote forms, while AmB-loaded BSA nanoparticles were more effective against amastigotes than promastigotes. AmB-D was more effective than AmB-loaded BSA nanoparticles in both forms, however, the lowest cytotoxicity against macrophages was achieved by AmB-nanoparticles. BALB/c mice treated with AmB-D or AmB-loaded BSA nanoparticles showed a significant decrease in the lesion thickness at the infected footpad. Histopathological analysis after 3 weeks of treatment revealed AmB-D-related toxicity in heart, spleen, lung, liver and kidneys, while treatment with AmB-loaded BSA nanoparticles did not reveal tissue toxicity. The antileishmanial efficacy and the reduced toxicity become BSA nanoparticles containing AmB a potential candidate for treating cutaneous leishmaniasis.
Collapse
Affiliation(s)
- D M Casa
- Department of Pharmacy, Laboratory of Pharmaceutical Nanotechnology, Universidade Estadual do Centro-Oeste-UNICENTRO, Rua Simeão Camargo Varela de Sá 03, Guarapuava, 85040-080, Brazil
| | - D B Scariot
- Department of Pharmacy, Laboratory of Technological Innovation in the Development of Drugs and Cosmetics, Universidade Estadual de Maringá Maringá-UEM, Avenida Colombo 5790, Maringá, PR 87020-900, Brazil
| | - N M Khalil
- Department of Pharmacy, Laboratory of Pharmaceutical Nanotechnology, Universidade Estadual do Centro-Oeste-UNICENTRO, Rua Simeão Camargo Varela de Sá 03, Guarapuava, 85040-080, Brazil
| | - C V Nakamura
- Department of Pharmacy, Laboratory of Technological Innovation in the Development of Drugs and Cosmetics, Universidade Estadual de Maringá Maringá-UEM, Avenida Colombo 5790, Maringá, PR 87020-900, Brazil
| | - R M Mainardes
- Department of Pharmacy, Laboratory of Pharmaceutical Nanotechnology, Universidade Estadual do Centro-Oeste-UNICENTRO, Rua Simeão Camargo Varela de Sá 03, Guarapuava, 85040-080, Brazil.
| |
Collapse
|
250
|
Stromer BS, Roy S, Limbacher MR, Narzary B, Bordoloi M, Waldman J, Kumar CV. Multicolored Protein Nanoparticles: Synthesis, Characterization, and Cell Uptake. Bioconjug Chem 2018; 29:2576-2585. [PMID: 29932667 DOI: 10.1021/acs.bioconjchem.8b00282] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Synthesis, characterization, and applications of strongly fluorescent, multicolored protein nanoparticles (GlowDots) are reported here. Bovine serum albumin was cross-linked under controlled conditions to form nanoparticles, where particle size was controlled from 20 to 100 ± 10 nm by choosing appropriate reaction conditions. The absorption as well as the emission wavelengths were controlled without changing the particle size, unlike quantum dots. Each GlowDot was loaded with up to 214 ± 50 chromophores, and hence, the particles have high molar absorptivities (106 M-1 cm-1) as well as high brightness (105 to 106 M-1 cm-1). A large number of functional groups cover the particle surface and these are further functionalized to enhance cellular uptake. GlowDots that were labeled with fluorescein and functionalized with taurine, for example, were quickly taken up by HeLa, MDA-MB-231, PC3, and L6 myoblast cells, as interrogated by fluorescence imaging studies. GlowDots were biocompatible, size tunable, biodegradable, strongly fluorescent, and stable for months at room temperature, and they may serve as substitutes for quantum dots in a variety of practical applications.
Collapse
Affiliation(s)
- Bobbi S Stromer
- Department of Chemistry , University of Connecticut , 55 North Eagleville Road , Storrs , Connecticut 06269-3060 , United States
| | - Sonali Roy
- Natural Product Chemistry Group, Chemical Sciences & Technology Division , CSIR-North East Institute of Science and Technology , Jorhat , Assam 785006 , India
| | - Melissa R Limbacher
- Department of Chemistry , University of Connecticut , 55 North Eagleville Road , Storrs , Connecticut 06269-3060 , United States
| | - Bardwi Narzary
- Natural Product Chemistry Group, Chemical Sciences & Technology Division , CSIR-North East Institute of Science and Technology , Jorhat , Assam 785006 , India
| | - Manobjyoti Bordoloi
- Natural Product Chemistry Group, Chemical Sciences & Technology Division , CSIR-North East Institute of Science and Technology , Jorhat , Assam 785006 , India
| | - Julia Waldman
- Department of Chemistry , University of Connecticut , 55 North Eagleville Road , Storrs , Connecticut 06269-3060 , United States
| | - Challa Vijaya Kumar
- Department of Chemistry , University of Connecticut , 55 North Eagleville Road , Storrs , Connecticut 06269-3060 , United States.,Department of Molecular and Cellular Biology , University of Connecticut , 91 North Eagleville Road , U-3125, Storrs , Connecticut 06269-3125 , United States
| |
Collapse
|